UBIQUITINYLIERTE PROTEINE

Patent europeic · EP3055322 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3055322
Numer da la dumonda
EP14851719
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
10-10-2014
Publitgà
17-08-2016
Concedì
25-09-2019
La protecziun finescha il pli tard
09-10-2034
Proxima taxa annuala scadenta
31-10-2026
Classas IPC
A61K 39/00 (2006.01)
Prioritad
US 201361890054 P 11.10.2013
Dumonda PCT
PCT/US2014/060180 10.10.2014
Publicaziun PCT
WO2015/054668 16.04.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-11-2025

    Midada

    Published in Swissreg on 01.11.2025

  2. 01-11-2024

    Midada

    Published in Swissreg on 01.11.2024

  3. 29-04-2024

    Midada

    Published in Swissreg on 29.04.2024

  4. 01-11-2022

    Midada

    Published in Swissreg on 01.11.2022

  5. 25-09-2019

    Concedì

    Published in Swissreg on 25.09.2019

Partidas

Possessur

Providence Health & Services - Oregon

1235 NE 47th Avenue, Portland, OR 97213, US

Ubivac, LLC

4805 NE Glisan Street, 5F58, Portland, Oregon 97213, US

Inventur

HU, Hong-Ming

Portland, Oregon 97232, US

LESHANE, Erik

Portland, Oregon 97206, US

YU, Guangjie

Hohhot Nei Mongol, CN

FOX, Bernard

Portland, Oregon 97213, US

TWITTY, Christopher

San Diego, California 92109, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.